; (B) increasing competition and addressing shortages in the prescription drug market; (C) improving public health; or (D) reducing the cost of prescription drugs to Federal and State health programs. (7) Manufacturing levels Not later than 1 year after the date of enactment of this section, the Office shall manufacture, or enter into contracts with entities for the manufacture of, not less than 15 applicable drugs. Not later than 3 years after such date of enactment, the Office shall manufacture, or enter into contracts with entities for the manufacture of, not less than 25 applicable drugs. (b) Submission of applications For each applicable drug that the Office determines should be manufactured, as provided for under this section, the Secretary shall— (1) submit an application under section 505(j) or 515 of the Federal Food, Drug, and Cosmetic Act or section 351(k) of the Public Health Service Act or submit a notification under section 510(k) of the Federal Food, Drug, and Cosmetic Act (or enter into a contract with another entity to submit such an application or notification)